• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A specific form of cPRC1 containing CBX4 is co-opted to mediate oncogenic gene repression in diffuse midline glioma.一种含有CBX4的特定形式的cPRC1被用于介导弥漫性中线胶质瘤中的致癌基因抑制。
Mol Cell. 2025 Jun 5;85(11):2110-2127.e7. doi: 10.1016/j.molcel.2025.04.026. Epub 2025 May 21.
2
PRC2.1- and PRC2.2-specific accessory proteins drive recruitment of different forms of canonical PRC1.PRC2.1 和 PRC2.2 特异性辅助蛋白驱动不同形式的经典 PRC1 的募集。
Mol Cell. 2023 May 4;83(9):1393-1411.e7. doi: 10.1016/j.molcel.2023.03.018. Epub 2023 Apr 7.
3
An exceptionally rare case of a diffuse midline glioma with concomitant H3.1 K27M and G34R mutations in the HIST1H3C (H3C3) gene.一例极为罕见的弥漫性中线胶质瘤病例,其HIST1H3C(H3C3)基因同时存在H3.1 K27M和G34R突变。
Acta Neuropathol Commun. 2025 Jan 16;13(1):7. doi: 10.1186/s40478-024-01899-5.
4
Integrated analyses reveal two molecularly and clinically distinct subtypes of H3 K27M-mutant diffuse midline gliomas with prognostic significance.整合分析揭示 H3 K27M 突变型弥漫性中线神经胶质瘤的两种具有预后意义的分子和临床明显不同亚型。
Acta Neuropathol. 2024 Sep 10;148(1):40. doi: 10.1007/s00401-024-02800-3.
5
H3F3A K27M mutations drive a repressive transcriptome by modulating chromatin accessibility independent of H3K27me3 in Diffuse Midline Glioma.在弥漫性中线胶质瘤中,H3F3A K27M突变通过独立于H3K27me3调节染色质可及性来驱动抑制性转录组。
Epigenetics Chromatin. 2025 Apr 26;18(1):23. doi: 10.1186/s13072-025-00585-7.
6
Therapeutic targeting of prenatal pontine ID1 signaling in diffuse midline glioma.产前桥脑 ID1 信号治疗弥漫性中线脑胶质瘤。
Neuro Oncol. 2023 Jan 5;25(1):54-67. doi: 10.1093/neuonc/noac141.
7
Genomic context- and H2AK119 ubiquitination-dependent inheritance of human Polycomb silencing.基因组背景和 H2AK119 泛素化依赖性的人类 Polycomb 沉默遗传。
Sci Adv. 2024 May 10;10(19):eadl4529. doi: 10.1126/sciadv.adl4529. Epub 2024 May 8.
8
Not all CBXs are created equal: A role for the disordered central region of CBX4 in pediatric glioma.并非所有的CBX蛋白都是一样的:CBX4无序的中央区域在小儿胶质瘤中的作用
Mol Cell. 2025 Jun 5;85(11):2061-2063. doi: 10.1016/j.molcel.2025.05.016.
9
Transcriptomic and epigenetic profiling of 'diffuse midline gliomas, H3 K27M-mutant' discriminate two subgroups based on the type of histone H3 mutated and not supratentorial or infratentorial location.弥漫性中线胶质瘤,H3 K27M 突变的转录组和表观遗传分析根据突变的组蛋白 H3 的类型而不是幕上或幕下位置对两个亚组进行区分。
Acta Neuropathol Commun. 2018 Nov 5;6(1):117. doi: 10.1186/s40478-018-0614-1.
10
Clinicohistoradiological and surgical outcome in diffuse midline glioma.弥漫性中线胶质瘤的临床-影像学和手术结果。
Childs Nerv Syst. 2024 Jan;40(1):65-71. doi: 10.1007/s00381-023-06095-9. Epub 2023 Aug 30.

引用本文的文献

1
Investigating oncoprotein-mediated chromatin dysregulation in uncovers novel modifiers of the developmental impact of H3 K27M and EZHIP.研究癌蛋白介导的染色质失调揭示了H3 K27M和EZHIP发育影响的新型调节因子。 (原英文文本似乎不完整,“in”后面缺少具体内容)
bioRxiv. 2025 May 27:2025.05.26.656136. doi: 10.1101/2025.05.26.656136.

本文引用的文献

1
A conserved switch to less catalytically active Polycomb repressive complexes in non-dividing cells.在非分裂细胞中向催化活性较低的多梳抑制复合物的保守转变。
Cell Rep. 2025 Jan 28;44(1):115192. doi: 10.1016/j.celrep.2024.115192. Epub 2025 Jan 11.
2
A deep catalogue of protein-coding variation in 983,578 individuals.983,578名个体蛋白质编码变异的深度目录。
Nature. 2024 Jul;631(8021):583-592. doi: 10.1038/s41586-024-07556-0. Epub 2024 May 20.
3
Principles of assembly and regulation of condensates of Polycomb repressive complex 1 through phase separation.通过相分离实现 Polycomb 抑制复合物 1 凝聚物的组装和调控原理。
Cell Rep. 2023 Oct 31;42(10):113136. doi: 10.1016/j.celrep.2023.113136. Epub 2023 Sep 26.
4
Pediatric diffuse midline glioma: Understanding the mechanisms and assessing the next generation of personalized therapeutics.小儿弥漫性中线胶质瘤:了解其机制并评估下一代个性化治疗方法。
Neurooncol Adv. 2023 Apr 12;5(1):vdad040. doi: 10.1093/noajnl/vdad040. eCollection 2023 Jan-Dec.
5
PRC2.1- and PRC2.2-specific accessory proteins drive recruitment of different forms of canonical PRC1.PRC2.1 和 PRC2.2 特异性辅助蛋白驱动不同形式的经典 PRC1 的募集。
Mol Cell. 2023 May 4;83(9):1393-1411.e7. doi: 10.1016/j.molcel.2023.03.018. Epub 2023 Apr 7.
6
BAF Complex Maintains Glioma Stem Cells in Pediatric H3K27M Glioma.BAF 复合物维持儿童 H3K27M 脑胶质瘤中的神经胶质瘤干细胞。
Cancer Discov. 2022 Dec 2;12(12):2880-2905. doi: 10.1158/2159-8290.CD-21-1491.
7
A Molecular Switch between Mammalian MLL Complexes Dictates Response to Menin-MLL Inhibition.哺乳动物 MLL 复合物之间的分子开关决定了对 Menin-MLL 抑制的反应。
Cancer Discov. 2023 Jan 9;13(1):146-169. doi: 10.1158/2159-8290.CD-22-0416.
8
Tazemetostat: EZH2 Inhibitor.他泽司他:EZH2抑制剂。
J Adv Pract Oncol. 2022 Mar;13(2):158-163. doi: 10.6004/jadpro.2022.13.2.7. Epub 2022 Mar 25.
9
A Chemical Strategy toward Novel Brain-Penetrant EZH2 Inhibitors.一种针对新型脑渗透性EZH2抑制剂的化学策略。
ACS Med Chem Lett. 2022 Feb 10;13(3):377-387. doi: 10.1021/acsmedchemlett.1c00448. eCollection 2022 Mar 10.
10
Hallmarks of Cancer: New Dimensions.癌症的特征:新视角。
Cancer Discov. 2022 Jan;12(1):31-46. doi: 10.1158/2159-8290.CD-21-1059.

一种含有CBX4的特定形式的cPRC1被用于介导弥漫性中线胶质瘤中的致癌基因抑制。

A specific form of cPRC1 containing CBX4 is co-opted to mediate oncogenic gene repression in diffuse midline glioma.

作者信息

Lagan Eimear, Gannon Dáire, Silva Ademar Jesus, Bibawi Peter, Doherty Anthony M, Nimmo Darragh, McCole Rachel, Monger Craig, Genesi Giovani Luiz, Vanderlinden Aurelie, Innes James A, Jones Charlotte L E, Yang Lu, Chen Bryan, van Mierlo Guido, Jansen Pascal W T C, Pednekar Chinmayi, Von Kriegsheim Alexander, Wynne Kieran, Sánchez-Rivera Francisco J, Soto-Feliciano Yadira M, Carcaboso Angel M, Vermeulen Michiel, Oliviero Giorgio, Chen Chun-Wei, Phillips Richard E, Bracken Adrian P, Brien Gerard L

机构信息

Smurfit Institute of Genetics, Trinity College Dublin, Dublin 2, Ireland; Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer University of Edinburgh, Edinburgh, UK; MRC Human Genetics Unit, Institute of Genetics and Cancer, The University of Edinburgh, Edinburgh, UK.

Smurfit Institute of Genetics, Trinity College Dublin, Dublin 2, Ireland.

出版信息

Mol Cell. 2025 Jun 5;85(11):2110-2127.e7. doi: 10.1016/j.molcel.2025.04.026. Epub 2025 May 21.

DOI:10.1016/j.molcel.2025.04.026
PMID:40403727
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12191925/
Abstract

Diffuse midline glioma (DMG) is a fatal childhood brain tumor characterized primarily by mutant histone H3 (H3K27M). H3K27M causes a global reduction in Polycomb repressive complex 2 (PRC2)-mediated H3K27 trimethylation (H3K27me3). Paradoxically, PRC2 is essential in DMG cells, although the downstream molecular mechanisms are poorly understood. Here, we have discovered a specific form of canonical PRC1 (cPRC1) containing CBX4 and PCGF4 that drives oncogenic gene repression downstream of H3K27me3 in DMG cells. Via a novel functional region, CBX4 preferentially associates with PCGF4-containing cPRC1. The characteristic H3K27me3 landscape in DMG rewires the distribution of cPRC1 complexes, with CBX4/PCGF4-cPRC1 accumulating at H3K27me3-enriched CpG islands. Despite comprising <5% of cPRC1 in DMG cells, the unique repressive functions of CBX4/PCGF4-cPRC1 are essential for DMG growth. Our findings link the altered distribution of H3K27me3 to imbalanced cPRC1 function, which drives oncogenic gene repression in DMG, highlighting potential therapeutic opportunities for this incurable childhood brain cancer.

摘要

弥漫性中线胶质瘤(DMG)是一种致命的儿童脑肿瘤,主要特征是突变的组蛋白H3(H3K27M)。H3K27M导致多梳抑制复合物2(PRC2)介导的H3K27三甲基化(H3K27me3)整体减少。矛盾的是,PRC2在DMG细胞中至关重要,尽管其下游分子机制尚不清楚。在这里,我们发现了一种包含CBX4和PCGF4的典型PRC1(cPRC1)的特定形式,它在DMG细胞中驱动H3K27me3下游的致癌基因抑制。通过一个新的功能区域,CBX4优先与含PCGF4的cPRC1结合。DMG中特征性的H3K27me3景观重塑了cPRC1复合物的分布,CBX4/PCGF4-cPRC1在富含H3K27me3的CpG岛处积累。尽管在DMG细胞中CBX4/PCGF4-cPRC1占cPRC1的比例不到5%,但其独特的抑制功能对DMG的生长至关重要。我们的研究结果将H3K27me3分布的改变与cPRC1功能失衡联系起来,后者驱动了DMG中的致癌基因抑制,突出了这种无法治愈的儿童脑癌潜在的治疗机会。